Sumatriptan, a selective 5-HT1B/1D receptor agonist, rapidly constricts cranial blood vessels and inhibits neuropeptide release, effectively alleviating the intense pain and autonomic symptoms associated with cluster headaches. When administered via subcutaneous injection or nasal spray, it provides rapid onset of action and significant pain relief by targeting serotonin receptors in the trigeminal vascular system.